Management of febrile neutropenia in immunocompetent children and youth

被引:1
|
作者
Lirette, Marie-Pier [1 ,2 ]
Wright, Nicola [1 ]
Trottier, Evelyne D. [1 ]
Beck, Carolyn E. [1 ]
机构
[1] Acute Care Comm, Canadian Paediat Soc, Ottawa, ON, Canada
[2] Canadian Paediat Soc, 100-2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada
基金
加拿大健康研究院;
关键词
Fever; Invasive bacterial infection; Neutropenia; Paediatric; SERIOUS BACTERIAL-INFECTION; CANCER; GUIDELINE; OUTCOMES; AGENTS; FEVER; RISK;
D O I
10.1093/pch/pxac127
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Febrile neutropenia is a common clinical presentation in children that can be associated with invasive bacterial infection (IBI). However, in otherwise healthy children and youth with fever and neutropenia, the risk for IBI is low, with most cases being caused by viral infections. Well-appearing, non-oncologic, and presumed immunocompetent children aged 6 months to 18 years experiencing a first episode of neutropenia, with no additional risk factors, typically do not require empiric antibiotics. However, a thorough assessment, including complete history and physical exam, is indicated, and a blood culture should be performed when the absolute neutrophil count is <0.5 x 10(9)/L. Close follow-up, a repeat complete blood count, and strong anticipatory guidance are recommended.
引用
收藏
页码:324 / 326
页数:3
相关论文
共 50 条
  • [21] Febrile neutropenia due to COVID-19 in an immunocompetent patient
    Devi, Yumkham Monica
    Sehrawat, Amit
    Panda, Prasan Kumar
    Nath, Uttam Kumar
    BMJ CASE REPORTS, 2021, 14 (04)
  • [22] Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children
    Eugene Leibovitz
    Joseph Kapelushnik
    Sabrin Alsanaa
    Dov Tschernin
    Ruslan Sergienko
    Ron Leibovitz
    Julia Mazar
    Yariv Fruchtman
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 2415 - 2426
  • [23] Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children
    Leibovitz, Eugene
    Kapelushnik, Joseph
    Alsanaa, Sabrin
    Tschernin, Dov
    Sergienko, Ruslan
    Leibovitz, Ron
    Mazar, Julia
    Fruchtman, Yariv
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (12) : 2415 - 2426
  • [24] Cost-effectiveness of Outpatient Management for Febrile Neutropenia in Children With Cancer
    Teuffel, Oliver
    Amir, Eitan
    Alibhai, Shabbir M. H.
    Beyene, Joseph
    Sung, Lillian
    PEDIATRICS, 2011, 127 (02) : E279 - E286
  • [25] Post-antibiotic management of immunocompromised children with febrile neutropenia.
    Russo, Carolyn Lucille
    Morgan, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [26] Outcome of two antibiotic regime in the management of febrile neutropenia in children with cancer
    Rahman, A. T. M.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 459 - 459
  • [27] Febrile neutropenia in children treated for malignancy
    Barton, Chris D.
    Waugh, Lucy K.
    Nielsen, Maryke J.
    Paulus, Stephane
    JOURNAL OF INFECTION, 2015, 71 : S27 - S35
  • [28] Role of Abelcet® in children with febrile neutropenia
    Le Guyader, N
    Auvrignon, A
    Demontoux, V
    Fasola, S
    Fratta, A
    Pellegrino, B
    Benoit, G
    Leverger, G
    PATHOLOGIE BIOLOGIE, 2004, 52 (09): : 550 - 555
  • [29] Thrombin generation in children with febrile neutropenia
    Yozgat, Ayca Koca
    Eker, Ibrahim
    Gursel, Orhan
    Kilinckaya, Muhammed Fevzi
    Kara, Abdurrahman
    Yarali, Nese
    Ozbek, Namik Yasar
    TURKISH JOURNAL OF PEDIATRICS, 2021, 63 (02) : 251 - 256
  • [30] Management of febrile neutropenia: Current strategies
    Bodey, G
    Rolston, KVI
    Sepkowitz, K
    Viscoli, C
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S237 - S238